Prevention strategies for adolescent depression

Bennett, Cheryl; Jones, Rhys Bevan; Smith, Daniel J.

doi:10.1192/apt.bp.112.010314

Cited by 7 publications

(5 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Rating scales have an important place in clinical practice and can be particularly helpful in monitoring an individual's progress. Bennett, Bevan Jones, and Smith () have also outlined a number of targeted prevention strategies for adolescent depression, whose benefits can be measured using appropriate rating scales. However, outcome measurement presents more difficulty when used to evaluate services due to difference in case mixes and regression to the mean (Lewis & Killaspy, ).…”

Section: Discussionmentioning

confidence: 99%

Measurement Issues: Depression measures in children and adolescents

Simmons

Wilkinson

Dubicka

2015

Child Adoles Ment Health

View full text Add to dashboard Cite

Background: Since the recognition of youth depression, numerous instruments have been developed, but there is little consensus regarding their use. In recent years, a national programme for outcome measurement has been introduced in the United Kingdom. Method: A pragmatic literature search was conducted to select instruments commonly used to measure depression either in research or as recommended by UK national bodies. Results: 15 depression rating scales were identified. Diagnostic instruments and rating scales are described. Conclusions: Recent large depression trials have produced additional new data, and UK national organisations have made recommendations regarding the implementation of certain instruments. Key Practitioner Message• Our pragmatic review identifies 15 of the most commonly used measures in recent large research trials, UK clinical practice and national guidelines. There is a lack of psychometric studies compared to the number of instruments that have been developed. However, there has been recent progress and increased interest in outcome measurement in UK services.• For treatment monitoring, the clinician-rated CDRS and the self-rated MFQ are brief, have good psychometric properties and a growing evidence-base. They can be readily incorporated into clinical practice to assess depressive symptoms.• There is a need for increased psychometric studies of youth-appropriate instruments, which could translate into improved international guidelines. Further research is needed on the development of cost-effective methods of implementing the use of diagnostic tools in clinical practice

show abstract

Section: Discussionmentioning

confidence: 99%

Measurement Issues: Depression measures in children and adolescents

Simmons

Wilkinson

Dubicka

2015

Child Adoles Ment Health

View full text Add to dashboard Cite

show abstract

“…There are also concerns about the economic burden of mental disorders 3 4. However, most adolescents with depression do not access or receive formal help and engaging young people (YP) in prevention and early intervention programmes is challenging 5–7…”

Section: Introductionmentioning

confidence: 99%

“…3 4 However, most adolescents with depression do not access or receive formal help and engaging young people (YP) in prevention and early intervention programmes is challenging. [5][6][7] strEngtHs And LIMItAtIons oF tHIs studY fi MoodHwb was codesigned with young people with lived experience or at high risk of depression, parents/carers and practitioners. fi MoodHwb is bilingual, personalised according to user needs and preferences, and has been developed in line with evidence-based approaches to support young people with depressive symptoms and their parents/carers, friends and practitioners.…”

Section: Introductionmentioning

confidence: 99%

Further development and feasibility randomised controlled trial of a digital programme for adolescent depression, MoodHwb: study protocol

et al. 2023

View full text Add to dashboard Cite

IntroductionA digital programme, MoodHwb, was codesigned with young people experiencing or at high risk of depression, parents/carers and professionals, to provide support for young people with their mood and well-being. A preliminary evaluation study provided support for the programme theory and found that MoodHwb was acceptable to use. This study aims to refine the programme based on user feedback, and to assess the acceptability and feasibility of the updated version and study methods.Methods and analysisInitially, this study will refine MoodHwb with the involvement of young people, including in a pretrial acceptability phase. This will be followed by a multicentre feasibility randomised controlled trial comparing MoodHwb plus usual care with a digital information pack plus usual care. Up to 120 young people aged 13–19 years with symptoms of depression and their parents/carers will be recruited through schools, mental health services, youth services, charities and voluntary self-referral in Wales and Scotland. The primary outcomes are the feasibility and acceptability of the MoodHwb programme (including usage, design and content) and of trial methods (including recruitment and retention rates), assessed 2 months postrandomisation. Secondary outcomes include potential impact on domains including depression knowledge and stigma, help-seeking, well-being and depression and anxiety symptoms measured at 2 months postrandomisation.Ethics and disseminationThe pretrial acceptability phase was approved by the Cardiff University School of Medicine Research Ethics Committee (REC) and the University of Glasgow College of Medicine, Veterinary and Life Sciences REC. The trial was approved by Wales NHS REC 3 (21/WA/0205), the Health Research Authority(HRA), Health and Care Research Wales (HCRW), university health board Research and Development (R&D) departments in Wales, and schools in Wales and Scotland. Findings will be disseminated in peer-reviewed open-access journals, at conferences and meetings, and online to academic, clinical, and educational audiences and the wider public.Trial registration numberISRCTN12437531.

show abstract

“…There are also concerns about the economic burden of mental disorders [2,3]. However, most adolescents with depression do not access or receive formal help and engaging young people (YP) in prevention and early intervention programmes is challenging [4][5][6].…”

Section: Introductionmentioning

confidence: 99%

Further development and feasibility randomised controlled trial of a digital programme for adolescent depression, MoodHwb: study protocol

Jones

Merry

Stallard

et al. 2022

Preprint

Self Cite

View full text Add to dashboard Cite

Introduction: A digital programme, MoodHwb, was co-designed with young people experiencing or at high risk of depression, parents/carers, and professionals, to provide support for young people with their mood and wellbeing. A preliminary evaluation study provided support for the programme theory and found that MoodHwb was acceptable to use. The present study aims to refine the programme based on user feedback, and to assess the acceptability and feasibility of the updated version and study methods. Methods and analysis: Initially, this study will refine MoodHwb with the involvement of young people, including in a pre-trial acceptability phase. This will be followed by a multi-centre feasibility randomised controlled trial comparing MoodHwb plus usual care with a digital information pack plus usual care. Up to 120 young people aged 13-19 years with symptoms of depression and their parents/carers will be recruited through schools, primary mental health services, youth services, charities, and voluntary self-referral in Wales and Scotland. The primary outcomes are the feasibility and acceptability of the MoodHwb programme (including usage, design, and content) and of trial methods (including recruitment and retention rates), assessed two months post-randomisation. Secondary outcomes include potential impact on domains including depression knowledge and stigma, help-seeking, wellbeing and depression and anxiety symptoms measured at two months post-randomisation. Ethics and dissemination: The pre-trial acceptability phase was approved by the Cardiff University School of Medicine Research Ethics Committee (REC) and the University of Glasgow College of Medicine, Veterinary and Life Sciences REC. The trial was approved by Wales NHS REC 3 (21/WA/0205), the Health Research Authority (HRA), Health and Care Research Wales (HCRW), university health board R&D departments in Wales, and schools in Wales and Scotland. Findings will be disseminated in peer-reviewed open-access journals, at conferences and meetings, and online to academic, clinical, and educational audiences and the wider public. Trial registration number:ISRCTN12437531.

show abstract

Prevention strategies for adolescent depression

Cited by 7 publications

References 46 publications

Measurement Issues: Depression measures in children and adolescents

Measurement Issues: Depression measures in children and adolescents

Further development and feasibility randomised controlled trial of a digital programme for adolescent depression, MoodHwb: study protocol

Further development and feasibility randomised controlled trial of a digital programme for adolescent depression, MoodHwb: study protocol

Contact Info

Product

Resources

About